LTR Pharma Limited (AU:LTP) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LTR Pharma Limited has partnered with Men’s Health Downunder to provide its innovative erectile dysfunction treatment, SPONTAN®, through an established pharmacy network in Australia. This collaboration leverages Men’s Health Downunder’s extensive referral network and is a strategic step in commercializing SPONTAN®, aiming for broader market access by early 2025. The partnership underscores LTR Pharma’s commitment to enhancing men’s health through trusted healthcare providers.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.